Altamira Therapeutics Ltd 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Altamira Therapeutics Ltd 's ROA in the fourth quarter of 2023?

However, within the Healthcare sector 948 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 4959.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Total Assets Change	16.74 %	-18.27 %	-25.64 %	17.83 %	12.89 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	-27	-27	-27	-27
Return On Assets (TTM)	0 %	-334.93 %	-321.7 %	-303.54 %	-320.82 %
CYTO's Total Ranking	# 4959	#	#	#	# 6377
Total Assets (TTM) in million	9	6	6	12	8
Seq. Total Assets Change	54.1 %	1.88 %	-54 %	61.65 %	7.88 %
Seq. Net Income Change	-	-	-	-	-

CYTO's 5 Years Annual ROA >> Back to CYTO Management Effectiveness >> Compare CYTO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 450
Sector	# 949
Overall	# 5335

Return On Assets Statistics
High	Average	Low
117.03 %	-37.48 %	-440.73 %
(Dec 31 2018)		(Dec 31 2022)

Financial Statements
Altamira Therapeutics Ltd 's Assets	$ 9 million	CYTO's Balance sheet
Altamira Therapeutics Ltd 's Income	$ 0 million	Quarterly CYTO's Income Statement
CYTO's Income by Division		See CYTO's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-53.13 %	96.01 %	-66.54 %	-44.72 %	106.45 %
Total Assets in million	6	12	6	19	34
Y / Y Net Income Change	-	-	-	113.42 %	30.98 %
Net Income in million	-8	-4	-28	19	9
Annual Return On Assets	-145.1 %	-34.62 %	-437.77 %	98.38 %	25.48 %

CYTO's 5 Years Annual ROA >> Back to CYTO Management Effectiveness >> Compare CYTO ROA to its Competitors

More Return On Assets Ratios
CYTO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYTO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYTO's Competitors
Subscribers only: Roa for Altamira Therapeutics Ltd 's Suppliers
Subscribers only: Return On Assets for CYTO's Customers

You may also want to know
CYTO's Roi	CYTO's Inventory Turnover Ratio	CYTO's Growth Rates	CYTO's Dividend Comparisons
	CYTO's Profitability Ratios	CYTO's Asset Turnover Ratio	CYTO's Dividend Growth
CYTO's Roe	CYTO's Valuation Ratios	CYTO's Financial Strength Ratios	CYTO's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector

ROA

Date modified: 2026-09-02T17:46:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.